article thumbnail

Navigating the challenges of cell therapies

Drug Target Review

in Chemistry from Villanova University and shortly thereafter began his scientific career in the Department of Microbiology at the University of Pennsylvania Medical School studying host-pathogen interactions. Dr Siciliano received a B.S. He then earned a Ph.D.

Therapies 116
article thumbnail

Mediating BRAF-mutant melanoma resistance

Drug Target Review

She went on to an internship in internal medicine at Yale-New Haven Hospital and a residency in dermatology at Harvard Medical School. She moved to Johns Hopkins in 1999 as an Assistant Professor of Oncology, Dermatology, and Molecular Biology and Genetics and was promoted to Associate Professor in 2004.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Advancing CAR-T therapy: how CD5 modulation is shaping cancer treatment

Drug Target Review

Dr Siciliano received a BS in chemistry from Villanova University and shortly thereafter began his scientific career in the Department of Microbiology at the University of Pennsylvania Medical School studying host-pathogen interactions.

article thumbnail

SRP-001: redefining pain treatment with a safer, non-opioid analgesic

Drug Target Review

Dr Hernan Bazan received a BS in molecular biology from Vanderbilt University and has spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH. He and his team have completed Phase I clinical trials, paving the way for Phase II RCTs in acute and neuropathic pain.

article thumbnail

Driving efficiency across upstream bioprocess workflow

Drug Target Review

He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard Medical School, and a PhD in virology/molecular biology. Anis also serves on the scientific and editorial advisory board of Genetic Engineering News at Mary Ann Liebert, Inc.

article thumbnail

Scientists find a region of the mouse gut tightly regulated by the immune system

Broad Institute

Isselbacher Professor of Medicine at Harvard Medical School, director of the Center for Computational and Integrative Biology and member of the Department of Molecular Biology at MGH, and co-director of the Center for Microbiome Informatics and Therapeutics at MIT.

article thumbnail

A surprising new role for a major immune regulator

Broad Institute

Now, a team of MIT, Massachusetts General Hospital (MGH), Broad Institute of MIT and Harvard, and Harvard Medical School (HMS) researchers has discovered how STING activates those two pathways. Paper Cited Liu B, Carlson R, et al. Human STING is a proton channel. Online August 3, 2023.